Peripheral microangiopathy in precapillary pulmonary hypertension: a nailfold video capillaroscopy prospective study.
Alexandra Arvanitaki, George Giannakoulas, Eva Triantafyllidou...
https://pubmed.ncbi.nlm.nih.gov/33478514/Actively Recruiting
Led by University of Glasgow · Updated on 2026-08-17
60
Participants Needed
1
Research Sites
10 weeks
Total Duration
Pulmonary hypertension PH is a rare condition causing high blood pressure in the lungs that can quickly lead to right heart failure and death. This research investigates whether changes in the small blood vessels of the nailbeds, measured by a non-invasive scan called Nailfold Capillaroscopy, relate to lung blood pressures measured by an invasive test called right heart catheterisation. The study aims to understand if these nailbed changes differ among PH types and if they reverse with treatment, especially in patients with pulmonary arterial hypertension related to systemic sclerosis SSc-PAH. Participants receive routine clinical care including pulmonary vasodilator drugs, which may include phosphodiesterase inhibitors, prostanoids, endothelin receptor antagonists, and activin ligand traps. Nailfold capillaroscopy scans are taken before and after treatment or treatment intensification, with images analyzed remotely using automated software. The study includes patients with different PH types such as SSc-PAH, non-SSc PAH, and PH due to lung or thromboembolic disease, aiming to compare nailbed vessel changes across these groups. Participants undergo assessments during inpatient diagnostic admission and outpatient visits, including clinical evaluations, quality of life questionnaires, exercise testing, imaging, and blood tests. Nailfold capillaroscopy images and a Raynauds condition score questionnaire are collected at baseline and follow-up visits 4 to 6 months later. Researchers measure changes in capillary density and patterns alongside standard disease severity markers like pulmonary pressures and functional tests. Data is securely stored and analyzed to explore correlations between nailbed vessel changes and treatment responses over time.
CONDITIONS
Nailfold Capillaroscopy in PH
W
William J Kerrigan, BA BMBCh MRCP
A
Alistair C Church, PhD, BSc, MB ChB, FRCP
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Glasgow
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 2 days for inpatient; 1 visit for outpatient
Participants undergo initial assessments during inpatient admission or outpatient clinic visits, including routine clinical tests, nailfold capillaroscopy scans, and questionnaires before starting or intensifying pulmonary vasodilator therapy.
1 inpatient or outpatient visit
Duration - 4 to 6 months
Participants continue pulmonary vasodilator therapy as part of standard care. Nailfold capillaroscopy scans and clinical assessments are repeated approximately 4 to 6 months after starting or increasing treatment to monitor changes.
1 to 2 visits during follow-up
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Have more questions? Get in touch with our team for quick support
Alexandra Arvanitaki, George Giannakoulas, Eva Triantafyllidou...
https://pubmed.ncbi.nlm.nih.gov/33478514/Silvia Bellando-Randone, Francesco Del Galdo, Gemma Lepri...
https://pubmed.ncbi.nlm.nih.gov/38287630/Praveen Gurunath Bharathi, Michael Berks, Graham Dinsdale...
https://pubmed.ncbi.nlm.nih.gov/36651676/Frank van den Hoogen, Dinesh Khanna, Jaap Fransen...
https://pubmed.ncbi.nlm.nih.gov/24092682/T L Moore, A Vail, A L Herrick
https://pubmed.ncbi.nlm.nih.gov/17116656/H M A Hofstee, A Vonk Noordegraaf, A E Voskuyl...
https://pubmed.ncbi.nlm.nih.gov/18375538/Maynara Santana-Gonçalves, Djúlio Zanin-Silva, Álvaro Henrique-Neto...
https://pubmed.ncbi.nlm.nih.gov/35368373/Christopher P Denton, Enrico De Lorenzis, Elen Roblin...
https://pubmed.ncbi.nlm.nih.gov/39255973/Anthony J Tyndall, Bettina Bannert, Madelon Vonk...
https://pubmed.ncbi.nlm.nih.gov/20551155/University of Glasgow
Lead Sponsor